Zucara Therapeutics

Zucara Therapeutics Inc is a spin-off of the Centre for Drug Research and Development and MaRS Innovation , is a company involved in a novel drug therapy to treat diabetes.In November 2016, the company recieved US $525,000 investment from Accel-Rx Health Sciences Accelerator, The Centre for Drug Research and Development (CDRD) and MaRS Innovation.In September 2022, Zucara Therapeutics Inc announced that its positive proof-of-concept data has enabled the Company to secure continued funding for a Phase 2 clinical study of ZT-01